Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 320.00
Bid: 313.00
Ask: 318.00
Change: 5.00 (1.59%)
Spread: 5.00 (1.597%)
Open: 320.00
High: 320.00
Low: 320.00
Prev. Close: 315.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output

Tue, 18th May 2021 08:13

(Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.
Oxford Biomedica, which has an 18-month supply deal with AstraZeneca to make its AZD1222 vaccine, lifted forecasts for expected cumulative revenues to more than £100m by end-2021 from more than £50m.

As a result, Oxford Biomedica said it expected 'significant growth' in annual operating earnings for the year to end-December.

More News
31 Jul 2020 11:06

IN BRIEF: Oxford Biomedica And Axovant Sign Clinical Supply Deal

IN BRIEF: Oxford Biomedica And Axovant Sign Clinical Supply Deal

Read more
31 Jul 2020 08:34

Oxford Biomedica signs supply deal with Axovant Gene Therapies

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a three-year clinical supply agreement with a wholly-owned subsidiary of Axovant Gene Therapies, it announced on Friday.

Read more
27 Jul 2020 08:13

LONDON BRIEFING: Ryanair Expect 60% Drop In Passengers In Current Year

LONDON BRIEFING: Ryanair Expect 60% Drop In Passengers In Current Year

Read more
15 Jul 2020 11:42

AstraZeneca Covid-19 vaccine shows promise - report

(Sharecast News) - A Covid-19 vaccine backed by AstraZeneca is producing positive results in initial trials, according to a report.

Read more
2 Jul 2020 17:54

DIRECTOR DEALINGS: Oxford Biomedica Director's Associate Buys Shares

DIRECTOR DEALINGS: Oxford Biomedica Director's Associate Buys Shares

Read more
24 Jun 2020 15:21

DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million

DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million

Read more
19 Jun 2020 14:40

IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments

IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments

Read more
18 Jun 2020 18:26

Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing

Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing

Read more
8 Jun 2020 17:12

Oxford Biomedica Says Sanofi To Return Rights To Two Programmes

Oxford Biomedica Says Sanofi To Return Rights To Two Programmes

Read more
8 Jun 2020 11:54

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine

UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine

Read more
8 Jun 2020 09:41

UPDATE 2-UK stocks end lower on concerns over corporate debt; AstraZeneca weighs

* AstraZeneca slips on report of potential merger with Gilead* Plus500 falls after big revenue hit from client trading wins* Oil & gas stocks gain after OPEC production cuts* BP rises after report of job cuts (Adds details, updates to close)By Shr...

Read more
3 Jun 2020 17:28

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC

Read more
1 Jun 2020 12:02

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO

Read more
1 Jun 2020 07:43

UPDATE 2-AstraZeneca scores twin drug approvals alongside vaccine progress

* Lynparza gains CHMP nod for advanced pancreatic cancer* Brilinta approved by FDA to cut risk of first heart attack* Coronavirus vaccine partner Oxford Biomedica appoints new chair (Writes through, adds detail, context)June 1 (Reuters) - Britain's...

Read more
28 May 2020 12:41

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

Oxford Biomedica Pens Virus Vaccine Supply Deal With AstraZeneca

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.